AUTOTAXIN INHIBITORY COMPOUNDS

The present invention relates to compounds of formula I, wherein A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar and Q are each as defined herein. The compounds of the present invention are inhibitors of autotaxin (ATX) enzyme activity. The present invention also relates to processes for the preparation o...

Full description

Saved in:
Bibliographic Details
Main Authors SHAH, PRITOM, STOCKLEY, MARTIN LEE, HITCHIN, JAMES, JORDAN, ALLAN, MACDONALD, ELLEN CATHERINE, HAMILTON, NIALL
Format Patent
LanguageEnglish
French
Published 28.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to compounds of formula I, wherein A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar and Q are each as defined herein. The compounds of the present invention are inhibitors of autotaxin (ATX) enzyme activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions (e.g. fibrosis) in which ATX activity is implicated. La présente invention concerne des composés de formule (I), dans laquelle A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar et Q sont chacun tels que définis dans la description. Les composés de la présente invention sont des inhibiteurs de l'activité enzymatique de l'autotaxine (ATX). La présente invention concerne également des procédés de préparation de ces composés, des compositions pharmaceutiques les comprenant, et leur utilisation dans le traitement de troubles prolifératifs, tels que le cancer, ainsi que d'autres maladies ou états pathologiques (par exemple, la fibrose) dans lesquels est impliquée l'activité d'ATX.
AbstractList The present invention relates to compounds of formula I, wherein A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar and Q are each as defined herein. The compounds of the present invention are inhibitors of autotaxin (ATX) enzyme activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions (e.g. fibrosis) in which ATX activity is implicated. La présente invention concerne des composés de formule (I), dans laquelle A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar et Q sont chacun tels que définis dans la description. Les composés de la présente invention sont des inhibiteurs de l'activité enzymatique de l'autotaxine (ATX). La présente invention concerne également des procédés de préparation de ces composés, des compositions pharmaceutiques les comprenant, et leur utilisation dans le traitement de troubles prolifératifs, tels que le cancer, ainsi que d'autres maladies ou états pathologiques (par exemple, la fibrose) dans lesquels est impliquée l'activité d'ATX.
Author JORDAN, ALLAN
MACDONALD, ELLEN CATHERINE
STOCKLEY, MARTIN LEE
HITCHIN, JAMES
SHAH, PRITOM
HAMILTON, NIALL
Author_xml – fullname: SHAH, PRITOM
– fullname: STOCKLEY, MARTIN LEE
– fullname: HITCHIN, JAMES
– fullname: JORDAN, ALLAN
– fullname: MACDONALD, ELLEN CATHERINE
– fullname: HAMILTON, NIALL
BookMark eNrjYmDJy89L5WSQcwwN8Q9xjPD0U_D08_B08gzxD4pUcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORpbmJkZmZs7GhFUAACsdIqc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSES INHIBITEURS DE L'AUTOTAXINE
ExternalDocumentID CA2974266C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2974266C3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:53:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2974266C3
Notes Application Number: CA20162974266
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230328&DB=EPODOC&CC=CA&NR=2974266C
ParticipantIDs epo_espacenet_CA2974266C
PublicationCentury 2000
PublicationDate 20230328
PublicationDateYYYYMMDD 2023-03-28
PublicationDate_xml – month: 03
  year: 2023
  text: 20230328
  day: 28
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies CANCER RESEARCH TECHNOLOGY LIMITED
RelatedCompanies_xml – name: CANCER RESEARCH TECHNOLOGY LIMITED
Score 3.4554749
Snippet The present invention relates to compounds of formula I, wherein A1, A2, A3, R1, R2, R3, R4, R5, R6, L, Ar and Q are each as defined herein. The compounds of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title AUTOTAXIN INHIBITORY COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230328&DB=EPODOC&locale=&CC=CA&NR=2974266C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MadQ3nZr5NXkwvBGxZcgeiIECARM-MpnBp2XtIPoyF4fx3_dKQH3ZW3NNrtem1_tde3cFuBULS6_ovaFxQdBBMSdE44ZRagbhlI75AkGKzB2OEzOcGU_FuOjBW5cL09QJ_W6KI6JGCdT3ujmv13-XWF4TW7m54-9I-ngMcttTW-8Y8TQlluq5tp-lXspUxmzmqMnUJoib0RaxHdiVIFpW2fdfXJmTsv5vUIIj2MuQ16o-hl65GsAB6_5dG8B-3D53Y7PVvM0JjHAjpblTRIkSJWHkRnk6fVVYGmfpLPGeT-Em8HMWajjQ_HdOc-Z0EtEz6KOnXw5B0bk-KU1ChC6IUVkPFuW8QhJHgYlYLs9huI3LxfauSziUKyMDp4h1Bf3686u8Rkta81GzCD9uRXS5
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MaZxvOjXza-PB8EbEUhg8EANlBHR8ZDKDT8vKIPoyF4fx3_cgoL7srbkm1_bS6_2uvbsC3GZLXS6UeyrxjKCDohlE4pTmEiVcUVS-RJBS5Q4HoebN6WOqph14a3Nh6jqh33VxRNSoDPW9rM_rzd8lllPHVm7v-DuSPh7cxHTExjtGPK0QXXRscxJHTsRExkxmieHMJIib0RaxPdgfV7V5K-D0Ylc5KZv_BsU9hoMYea3LE-jk6z70WPvvWh8Og-a5G5uN5m1PYYgbKUqs1A8FP_R820-i2avAoiCO5qHzfAYjd5IwT8KBFr9rWjCrnZFyDl309PMBCDKXjVwjJJMzQgt9rCucF0jiqkFJtlpdwGAXl8vdXSPoeUkwXUz98OkKjiopVUFURL-Gbvn5ld-gVS35sBbIDws_d6Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AUTOTAXIN+INHIBITORY+COMPOUNDS&rft.inventor=SHAH%2C+PRITOM&rft.inventor=STOCKLEY%2C+MARTIN+LEE&rft.inventor=HITCHIN%2C+JAMES&rft.inventor=JORDAN%2C+ALLAN&rft.inventor=MACDONALD%2C+ELLEN+CATHERINE&rft.inventor=HAMILTON%2C+NIALL&rft.date=2023-03-28&rft.externalDBID=C&rft.externalDocID=CA2974266C